Pulmonary arterial hypertension (PAH) is a life-threatening disorder that ultimately causes heart failure. In this study, the authors used a shRNA lentiviral vector which targets Bcl2 and another which expresses hypoxia response element (HRE) to understand the causes of PAH. Their results suggest that HRE-mediated Bcl-2 inhibition can effectively attenuate hypoxia-induced apoptosis resistance in pulmonary microvascular endothelial cells by downregulating Bcl-2 expression and upregulating caspase-3 and P53 expression. This study therefore reveals critical insight into potential therapeutic targets for treating PAH.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
Pulmonary arterial hypertension (PAH) is a life-threatening disorder that ultimately causes heart failure. In this study, the authors used a shRNA lentiviral vector which targets Bcl2 and another which expresses hypoxia response element (HRE) to understand the causes of PAH. Their results suggest that HRE-mediated Bcl-2 inhibition can effectively attenuate hypoxia-induced apoptosis resistance in pulmonary microvascular endothelial cells by downregulating Bcl-2 expression and upregulating caspase-3 and P53 expression. This study therefore reveals critical insight into potential therapeutic targets for treating PAH.
www.geg-tech.com/Vectors